Indivior settles addiction drug dispute with Par

Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Indivior pledges to appeal generic Suboxone decision

26 March 2018 UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents.

Americas

Indivior to appeal court verdict over Suboxone Film patents

4 September 2017 Indivior, which specialises in addiction treatment drugs, intends to launch an appeal against a US District Court for the District of Delaware verdict that could lead to rival companies selling a generic version of its Suboxone Film, a drug to treat opioid addiction.

Americas

Indivior obtains court order to block generic Suboxone

18 June 2018 Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.

More on this story

Americas

Indivior pledges to appeal generic Suboxone decision

26 March 2018 UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents.

Americas

Indivior to appeal court verdict over Suboxone Film patents

Americas

Indivior obtains court order to block generic Suboxone

More on this story

Americas

Indivior pledges to appeal generic Suboxone decision

26 March 2018 UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents.

Americas

Indivior to appeal court verdict over Suboxone Film patents

Americas

Indivior obtains court order to block generic Suboxone